877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Psychopharmacology, Nervous system drug

Categories

Drugs acting on the nervous system (43)
Psychoactive drugs (43)
Antidepressants (29)
Cyclic compounds (24)
Aromatic compounds (18)
Antipsychotics (17)
Psychoanaleptics (17)
Amines (12)
Bases (chemistry) (12)
Dopamine antagonists (12)
Pharmaceuticals (10)
Six-membered rings (10)
Typical antipsychotics (9)
Fluoroarenes (8)
Antihypertensive agents (5)
Anxiolytics (5)
Drugs acting on the cardiovascular system (5)
Monoamine oxidase inhibitors (5)
Monoamine reuptake inhibitors (5)
Tetracyclic antidepressants (5)
Alcohols (4)
Alpha blockers (4)
Antihistamines (4)
Chloroarenes (4)
Drugs acting on the genito-urinary system (4)
Drugs for benign prostatic hyperplasia (4)
Five-membered rings (4)
H1 receptor antagonists (4)
Piperazines (4)
Piperidines (4)
Psycholeptics (4)
Selective serotonin reuptake inhibitors (4)
Urologicals (4)
Alpha-2 blockers (3)
Azapirones (3)
Cycloalkanes (3)
Cyclopentanes (3)
Dibenzazepines (3)
Noradrenergic and specific serotonergic antidepressants (3)
Norepinephrine reuptake inhibitors (3)
Organic compound (3)
Tricyclic antidepressants (3)
Aromatic ketones (2)
Benzodioxins (2)
Diphenylbutylpiperidines (2)
Morpholines (2)
Reversible inhibitors of MAO-A (2)
Acids (1)
Alpha-1 blockers (1)
Analgesics (1)
Anorectics (1)
Antihypertensive agent (1)
Antiobesity drugs (1)
Antiparkinsonian agents (1)
Atypical antipsychotics (1)
Bromoarenes (1)
Carbazoles (1)
Carboxylic acids (1)
Cardiovascular system drug (1)
Dopamine agonists (1)
Drugs acting on the gastrointestinal system and metabolism (1)
Drugs acting on the musculoskeletal system (1)
Halides (1)
Musculoskeletal system drug (1)
Nootropics (1)
Organic acids (1)
Organobromides (1)
Organohalides (1)
Oximes (1)
Phenethylamines (1)
Serotonin reuptake inhibitors (1)
Serotonin-norepinephrine-dopamine reuptake inhibitors (1)
Spiro compounds (1)
Stimulants (1)
Substituted amphetamines (1)
Thiadiazoles (1)
Ureas (1)
Xanthines (1)

Suppliers

Sigma Aldrich (4)
Toronto Research Chemicals (2)
AK Scientific (1)
Matrix Scientific (1)

mirtazapine (61337-67-5, 85650-52-8)  
Remeron  ·  Rexer  ·  ORG 3770
Mirtazapine, sold under the brand name Remeron among others, is an atypical antidepressant which is used primarily in the treatment of depression. In addition to its antidepressant properties, mirtazapine has anxiolytic, sedative, antiemetic, and appetite stimulant effects and is sometimes used in the treatment of anxiety disorders, insomnia, nausea and vomiting, and to produce weight gain when desirable. It is taken by mouth.
BUTAPERAZINE (653-03-2)  
butyrylperazine
Butaperazine (Repoise, Tyrylen) is a typical antipsychotic of the phenothiazine class.
Esmirtazapine (61337-87-9)  
mirtazapine  ·  Remeron  ·  Rexer
Esmirtazapine (ORG-50,081) is a drug which was under development by Organon for the treatment of insomnia and vasomotor symptoms (e.g., hot flashes) associated with menopause. Esmirtazapine is the (S)-(+)-enantiomer of mirtazapine and possesses similar overall pharmacology, including inverse agonist actions at H1 and 5-HT2 receptors and antagonist actions at α2-adrenergic receptors. As of March 2010, Merck terminated internal clinical development program for esmirtazapine, for hot flashes and insomnia, for strategic reasons.
ACETOPHENAZINE (2751-68-0)  
Acetophenazine (Tindal) is a typical antipsychotic of the phenothiazine class.
Fluspirilene (1841-19-6)  
Imap  ·  Fluspirilen beta  ·  Hexal Brand of Fluspirilene
Fluspirilene (Redeptin, Imap, R6218) is a diphenylbutylpiperidine typical antipsychotic drug, used for the treatment of schizophrenia. It is administered intramuscularly. It was discovered at Janssen Pharmaceutica in 1963.
Dimetacrine (4757-55-5)  
Dimetacrine (brand names Istonil, Istonyl, Linostil, Miroistonil), also known as dimethacrine and acripramine, is a tricyclic antidepressant (TCA) used in Europe and formerly in Japan for the treatment of depression. It has imipramine-like effects; though, in a double-blind clinical trial against imipramine, dimetacrine was found to have lower efficacy in comparison and produced more weight loss and abnormal liver tests. Little is known about the pharmacology of dimetacrine, but it can be inferred that it acts in a similar manner to other TCAs.
bromperidol (10457-90-6)  
R 11,333  ·  bromperidol, 82Br-labeled  ·  Tesoprel
Bromperidol (marketed as Bromidol, Bromodol) is a butyrophenone derivative. It is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophrenia. It was discovered at Janssen Pharmaceutica in 1966.
Desmethylcitalopram (670-75-7, 144025-14-9, 62498-67-3)  
monodesmethylcitalopram monohydrochloride  ·  monodesmethylcitalopram oxalate  ·  monodesmethylcitalopram
Desmethylcitalopram is an active metabolite of the antidepressant drugs citalopram (racemic) and escitalopram (the S-enantiomer, which would be called desmethylescitalopram). Like citalopram and escitalopram, desmethylcitalopram functions as a selective serotonin reuptake inhibitor (SSRI), and is responsible for some of its parents' therapeutic benefits.
Cyamemazine (3546-03-0)  
cyamamazine  ·  10-(3-dimethylamino-2-methylpropyl)phenothiazine-2-carbonitrile  ·  cyamepromazine
Cyamemazine (Tercian), also known as cyamepromazine, is a typical antipsychotic drug of the phenothiazine class which was introduced by Theraplix in France in 1972 and later in Portugal as well. It is used for the treatment of schizophrenia and, especially, for psychosis-associated anxiety, due to its unique anxiolytic efficacy. Cyamemazine differs from other phenothiazine neuroleptics in that aside from the usual profile of dopamine, α1-adrenergic, H1, and mACh receptor antagonism, it additionally produces potent blockade of several serotonin receptors, including 5-HT2A, 5-HT2C, and 5-HT7.
Clothiapine (2058-52-8)  
Entumine  ·  clotiapine
Clotiapine (Entumine) is an atypical antipsychotic of the dibenzothiazepine chemical class. It was first introduced in a few European countries (namely, Belgium, Italy, Spain and Switzerland), Argentina, Taiwan and Israel in 1970. Some sources regard clotiapine as a typical antipsychotic rather than atypical due to its high incidence of extrapyramidal side effects compared to the atypicals like clozapine and quetiapine, to which it is structurally related.
Bifemelane (62232-46-6, 90293-01-9)  
MCI-2016  ·  2-(4-methylaminobutoxy)diphenylmethane  ·  Celeport
Bifemelane (INN) (Alnert, Celeport), or bifemelane hydrochloride (JAN), also known as 4-(O-benzylphenoxy)-N-methylbutylamine, is an antidepressant and cerebral activator that is widely used in the treatment of cerebral infarction patients with depressive symptoms in Japan, and in the treatment of senile dementia as well. It also appears to be useful in the treatment of glaucoma. Bifemelane acts as a monoamine oxidase inhibitor (MAOI) of both isoenzymes, with competitive (reversible) inhibition of MAO-A (Ki = 4.20 μM) (making it a reversible inhibitor of monoamine oxidase A (RIMA)) and non-competitive (irreversible) inhibition of MAO-B (Ki = 46.0 μM), and also acts (weakly) as a norepinephrine reuptake inhibitor.
BENPERIDOL (2062-84-2)  
Benperidol-neuraxpharm  ·  Glianimon  ·  Frenactil
Benperidol is a drug which is a highly potent butyrophenone derivative. It is the most potent neuroleptic on the European market, with chlorpromazine equivalency as high as 75 to 100 (about 150 to 200% potency in terms of dose compared to haloperidol). It is an antipsychotic, which can be used for the treatment of schizophrenia, but it is primarily used to control antisocial hypersexual behaviour, and is sometimes prescribed to sex offenders as a condition of their parole, as an alternative to anti-androgen drugs such as cyproterone acetate.
Fluanisone (1480-19-9)  
fluanisone dihydrochloride  ·  haloanisone  ·  fluanisone monohydrochloride
Fluanisone is a typical antipsychotic and sedative of the butyrophenone chemical class. It is used in the treatment of schizophrenia and mania. It is also a component (along with fentanyl) of the injectable veterinary formulation Hypnorm where it is used for rodent analgesia during short surgical procedures.
Brofaromine (63638-91-5)  
Brofaromine (proposed brand name Consonar) is a reversible inhibitor of monoamine oxidase A (RIMA) discovered by Ciba-Geigy. The compound was primarily researched in the treatment of depression and anxiety but its development was dropped before it was brought to market. Brofaromine also acts as a serotonin reuptake inhibitor, and its dual pharmacologic effects offered promise in the treatment of a wide spectrum of depressed patients while producing less severe anticholinergic side effects in comparison with older standard drugs like the tricyclic antidepressants.
Alaproclate (60719-82-6)  
alaproclate hydrochloride, (D)-isomer  ·  A 23189  ·  alaproclate hydrochloride
Alaproclate (developmental code name GEA-654) is a drug that was being developed as an antidepressant by the Swedish pharmaceutical company Astra AB (now AstraZeneca) in the 1970s. It acts as a selective serotonin reuptake inhibitor (SSRI), and along with zimelidine and indalpine, was one of the first of its kind. Development was discontinued due to the observation of liver complications in rodent studies.
(+)-Butaclamol (56245-67-1)  
Butaclamol (AY-23,028) is a typical antipsychotic which was never marketed. Sold as the hydrochloride salt for use in research, the compound acts as a dopamine receptor antagonist.
Eprobemide (87940-60-1)  
Eprobemide (INN) is a pharmaceutical drug that was used as an antidepressant in Russia (under the brand name Бефол/Befol). It is a non-competitive reversible inhibitor of monoamine oxidase A that exhibits selective action on serotonin deamination. Eprobemide differs from moclobemide only in linker that connects morpholine fragment with chlorobenzamide—moclobemide has two carbon atoms while eprobemide has three.
Exp 561 (10206-89-0)  
EXP-561 is an investigational drug that acts as an inhibitor of the reuptake of serotonin, dopamine, and norepinephrine. It was developed in the 1960s by Du Pont and was suggested as a potential antidepressant but failed in trials and was never marketed.
FLUCINDOLE (40594-09-0)  
Flucindole is an antipsychotic with a tricyclic structure that was never marketed. It is the 6,8-difluoro derivative of cyclindole.
Related searches
Psychopharmacology
Nervous system drug
Next Page >